Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
7
×
life sciences
national blog main
biotech
clinical trials
san francisco blog main
boston top stories
san francisco top stories
fda
raleigh-durham blog main
abbvie
cancer
indiana blog main
multiple myeloma
national
national top stories
new york blog main
raleigh-durham top stories
san diego blog main
seattle blog main
agios pharmaceuticals
american society of hematology
beta-thalassemia
blood diseases
bluebird bio
boston
boulder/denver blog main
boulder/denver top stories
cancer diagnostics
cooley's anemia foundation
detroit blog main
detroit top stories
drugs
freenome
gene therapy
global blood therapeutics
grail
ibrutinib
imbruvica
indiana top stories
What
blood
7
×
medical
developing
tests
american
ash
cancer
company
diabetes
diego
gathering
intended
largest
levels
medicine
san
society
sugar
treatments
week
advance
anemia
announced
annual
area
available
balance
based
bay
beta
big
biome
bionics
biopsy
body
borne
broader
buildout
cancers
carry
Language
unset
Current search:
blood
×
" boston blog main "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
5 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More